Common side effects may include nausea and vomiting
If metformin is ineffective, alternatives include SGLT2 inhibitors, GLP-1 agonists, thiazolidinediones, DPP-4 inhibitors, or sulfonylureas, often combined with lifestyle changes like diet and exercise
Use of NOVOLOG for this indication is supported by evidence from an adequate and well-controlled study in 283 pediatric patients with type 1 diabetes mellitus aged 6 to 18 years and from studies in adults with diabetes mellitus [see Adverse Reactions (6.1), Clinical Pharmacology (12.3), and Clinical Studies (14)]
guanethidine or rifamycins A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g
: 3,75 /
With obesity rates in the UK now at very high levels, and associated with substantial multimorbidity, additional treatment options for sustained weight loss are greatly needed. Jason Murphy, the head of pharmacy at Chemist4U, said the announcement was a major step forward in treating obesity, increasing access and enabling millions more people to get treatment